| Corpus Christi Medical Center | |
|
13725 Northwest Boulevard Corpus Christi TX 78410-5127 | |
| (361) 761-1000 | |
| (361) 857-5960 |
| Full Name | Corpus Christi Medical Center |
|---|---|
| Speciality | Psychiatric Unit |
| Location | 13725 Northwest Boulevard, Corpus Christi, Texas |
| Authorized Official Name and Position | Chris Nicosia (CFO) |
| Authorized Official Contact | 3617611501 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Corpus Christi Medical Center 3315 South Alameda Corpus Christi TX 78411-1820 Ph: (361) 761-1000 | Corpus Christi Medical Center 13725 Northwest Boulevard Corpus Christi TX 78410-5127 Ph: (361) 761-1000 |
| NPI Number | 1043449143 |
|---|---|
| Provider Enumeration Date | 07/09/2009 |
| Last Update Date | 11/03/2009 |
| Medicare PECOS PAC ID | 0446145569 |
|---|---|
| Medicare Enrollment ID | O20091002000114 |
News Archive
Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.
New research led by the University of Leicester in the UK gives a blow-by-blow account of the injuries inflicted on King Richard III's body at the Battle of Bosworth Field on Aug 22, 1485. Modern forensic analysis of the King's skeletal remains reveals that three of his injuries had the potential to cause death quickly—two to the skull and one to the pelvis.
pSivida Limited has announced that it has initiated a full development programme of its proprietary BrachySil product in a second key cancer indication. Development has commenced to evaluate the efficacy and safety of this novel brachytherapy product in pancreatic cancer, with the clinical programme scheduled to commence before the end of 2005.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair (EVAR) utilizing the Company's IntuiTrak(TM) endovascular delivery system for the Powerlink® family of stent grafts.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043449143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 273R00000X | Psychiatric Unit | (* (Not Available)) | Primary |
News Archive
Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.
New research led by the University of Leicester in the UK gives a blow-by-blow account of the injuries inflicted on King Richard III's body at the Battle of Bosworth Field on Aug 22, 1485. Modern forensic analysis of the King's skeletal remains reveals that three of his injuries had the potential to cause death quickly—two to the skull and one to the pelvis.
pSivida Limited has announced that it has initiated a full development programme of its proprietary BrachySil product in a second key cancer indication. Development has commenced to evaluate the efficacy and safety of this novel brachytherapy product in pancreatic cancer, with the clinical programme scheduled to commence before the end of 2005.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair (EVAR) utilizing the Company's IntuiTrak(TM) endovascular delivery system for the Powerlink® family of stent grafts.
› Verified 9 days ago
Corpus Christi Class Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4230 S. Padre Island Dr., Suite B, Corpus Christi, TX 78411 Phone: 361-855-1886 | |
Coastal Bend Neurology Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5920 Saratoga Blvd, Suite 500, Corpus Christi, TX 78414 Phone: 361-994-8883 | |
Carroll Ann Williams Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5151 Flynn Pkwy Ste 412f, Corpus Christi, TX 78411 Phone: 361-290-9330 | |
Circles Of Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5333 Everhart Rd Ste 150b, Corpus Christi, TX 78411 Phone: 361-852-3812 Fax: 361-852-6124 | |
Coastal Bend Psychiatric Associates P.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6625 Wooldridge Rd, Ste 201, Corpus Christi, TX 78414 Phone: 361-993-8358 Fax: 361-993-8874 | |
Macy Kinzel, Ph.d., P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3434 S Alameda St, Corpus Christi, TX 78411 Phone: 361-855-2710 Fax: 361-855-4204 | |
Aaverlee Clinical Associates Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4455 S Padre Island Dr, Suite 101, Corpus Christi, TX 78411 Phone: 361-814-2273 Fax: 361-814-2274 |